business
TME Pharma extends financial visibility by lengthening debt maturity to June 2028
TME Pharma extends financial visibility by lengthening debt maturity to June 2028 Financial visibility extended to second quarter of 2028All existing debt holders, including the CEO and two members of the Supervisory Board,
Latest updates
TME Pharma extends financial visibility by lengthening debt maturity to June 2028
TME Pharma extends financial visibility by lengthening debt maturity to June 2028 Financial visibility extended to second quarter of 2028All existing debt holders, including the CEO and two members of the Supervisory Board,